MFE:PA:PA-Lyxor UCITS MSCI EMU (EUR)

ETF | Others |

Last Closing

USD 64.11

Change

+0.49 (+0.77)%

Market Cap

USD 0.42B

Volume

7.14K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.35 (+0.74%)

USD 64.41B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+3.50 (+0.68%)

USD 12.63B
WRD:PA HSBC ETFs Public Limited Compa..

+0.21 (+0.64%)

USD 10.26B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+0.95 (+0.39%)

USD 8.94B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+3.70 (+0.84%)

USD 7.98B
HHH:PA HSBC ETFs Public Limited Compa..

+0.36 (+0.70%)

USD 7.03B
WLD:PA Lyxor UCITS MSCI World D-EUR

+2.09 (+0.62%)

USD 6.87B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.13 (+0.73%)

USD 6.47B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+2.11 (+0.57%)

USD 5.17B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

+0.68 (+0.46%)

USD 4.78B

ETFs Containing MFE:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.11% 52% F 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.11% 49% F 65% D
Trailing 12 Months  
Capital Gain 18.09% 42% F 62% D
Dividend Return 2.76% 63% D 40% F
Total Return 20.85% 53% F 67% D+
Trailing 5 Years  
Capital Gain 37.32% 47% F 63% D
Dividend Return 11.57% 57% F 46% F
Total Return 48.89% 55% F 65% D
Average Annual (5 Year Horizon)  
Capital Gain 8.63% N/A N/A 61% D-
Dividend Return 10.98% N/A N/A 66% D+
Total Return 2.35% N/A N/A 57% F
Risk Return Profile  
Volatility (Standard Deviation) 15.74% N/A N/A 64% D
Risk Adjusted Return 69.76% N/A N/A 76% C+
Market Capitalization 0.42B 61% D- 67% D+

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike